Array Digital Infrastructure beat Q2 estimates as site rental revenues surge 95%, while spectrum sal

Array Digital Infrastructure (AD) came out with quarterly earnings of $0.64 per share, beating the Z

Array Digital Infr (NYSE:AD) reported quarterly earnings of $3.86 per share which beat the analyst c

Array Digital Infr (NYSE:AD) raises FY2026 sales outlook from $200.000 million-$215.000 million to $

Array updates 2026 guidance CHICAGO, Aug. 7, 2026 /PRNewswire/ -- As previously announced, Array wil

Array Digital, Optimum and AT&T have been highlighted in this Industry Outlook article.

AD, OPTU and T are likely to ride long-term gains from 5G momentum and rising demand for wireless co

CHICAGO, July 31, 2026 /PRNewswire/ -- Telephone and Data Systems, Inc. (NYSE: TDS) and Array Digita

Dimensional Fund Advisors LP increased its holdings in Array Digital Infrastructure Inc. (NYSE: AD)

CAMBRIDGE, Mass.--(BUSINESS WIRE)--LAPIX Therapeutics has appointed Abbas Kazimi, Chief Executive Of

More than 75% of LeqembiÂ-treated patients remained stable and nearly 7% improved over an average of

LEQEMBIÂ Real-World LEADER Study Presented at AAICÂ 2026 Finds Over 75% of Early Alzheimer's Patient

LEQEMBIÂ Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulat

RBC Capital analyst Jonathan Atkin maintains Array Digital Infr (NYSE:AD) with a Sector Perform a

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQÂ) for the Treatment of Adults and Ado

Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP)

FORT LAUDERDALE, Fla., June 23, 2026 (GLOBE NEWSWIRE) -- AD Mortgage , a leading wholesale lender in

NOT FOR DISTRIBUTION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A

VANCOUVER, British Columbia, June 18, 2026 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc., a V

BRONX, N.Y.--(BUSINESS WIRE)-- #Alzheimers--Oligomerix, Inc., a privately held clinical stage compan

CAMBRIDGE, Mass. and TAIPEI, June 10, 2026 /PRNewswire/ -- Elixiron Immunotherapeutics (TPEx: 7871),

On June 10, 2026, Array Digital Infrastructure Inc (AD) shares rose 3.1% to a current price of $52.3

First Patient Enrolled in New Study Assessing early prediction of flares in Atopic Dermatitis by Cas

May 11, 2026: 2 stocks in communication services sector show warning to investors valuing momentum;

Array Digital Infr (NYSE:AD) affirms FY2026 sales outlook from $200.000 million-$215.000 million to

Array Digital Infr (NYSE:AD) reported quarterly earnings of $2.06 per share which beat the analyst c

Array Digital Infrastructure, Inc. (NYSE:AD) ("Array" or the "Company") confirmed to

Telephone and Data Systems, Inc. (NYSE: TDS) (the "Company" or "TDS") today announce

RBC Capital analyst Jonathan Atkin maintains Array Digital Infr (NYSE:AD) with a Outperform and l

Citigroup analyst Michael Rollins maintains Array Digital Infr (NYSE:AD) with a Buy and lowers th

Array Digital Infr (NYSE:AD) reported quarterly earnings of $0.48 per share which beat the analyst c

Array Digital Infr (NYSE:AD) sees FY2026 sales of $200.000 million-$215.000 million vs $194.393 mill

Wells Fargo analyst Eric Luebchow maintains Array Digital Infr (NYSE:AD) with a Overweight and lo

Citigroup analyst Michael Rollins maintains Array Digital Infr (NYSE:AD) with a Buy and raises th

Citigroup analyst Michael Rollins reinstates Array Digital Infr (NYSE:AD) with a Buy and announce

RBC Capital analyst Jonathan Atkin maintains Array Digital Infr (NYSE:AD) with a Outperform and l

TDS stock falls after reporting Q3 earnings. Revenue from continuing operations was $308.52 million.

Array Digital Infr (NYSE:AD) reported quarterly sales of $47.119 million which beat the analyst cons

Array Digital Infrastructure, Inc. SM (NYSE:AD) (ArraySM), and Telephone and Data Systems, Inc. (NYS

Wells Fargo analyst Eric Luebchow maintains Array Digital Infr (NYSE:AD) with a Overweight and lo